Clinical Trials Browser

Terminated × masitinib × Gastrointestinal × Clear all

NCT00812240 2023-02-01

Masitinib in First Line Treatment of Gastro-Intestinal Stromal Tumor (GIST)

Phase 3 Terminated

GastrointestinalSarcoma

Neoplasm Metastasis, Gastrointestinal Stromal Tumors

NCT02605044 2019-02-11

Masitinib in Combination With FOLFIRI for Second-line Treatment of Patients With Metastatic Colorectal Cancer

Phase 3 Terminated

Gastrointestinal

Colorectal Neoplasms